Drugs Made In America Acquisition II Corp. (DMII)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 22, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Cantor Fitzgerald & Co. to the SEC requests the acceleration of the effective date for the Registration Statement of Drugs Made In America Acquisition II C… | Read Filing EDGAR |
| Sep. 22, 2025 | CORRESP | Neutral/Informational | Moderate | Drugs Made In America Acquisition II Corp. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1. They seek to h… | Read Filing EDGAR |
| Sep. 16, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Drugs Made In America Acquisition II Corp. addresses comments from the SEC regarding their Registration Statement on Form S-1. The company has submitted Am… | Read Filing EDGAR |
| Sep. 15, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed the amended registration statement for Drugs Made In America Acquisition II Corp. and has raised concerns regarding the transfer of founder shares to certain … | Read Filing EDGAR |
| Jul. 18, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Drugs Made In America Acquisition II Corp. addresses comments from the SEC regarding their Draft Registration Statement on Form S-1. The company has submit… | Read Filing EDGAR |
| May. 2, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has reviewed the amended draft registration statement submitted by Drugs Made In America Acquisition II Corp. and has issued a comment regarding the disclosure of conflict… | Read Filing EDGAR |